- West, R. Enhancing Motivation to Stop Smoking: From Theory to Practice. Cancer Research UK. UK Centre for Tobacco Control Studies: A UKCRC Public Health Centre of Excellence. August, 2014.
- Reid JL, Hammond D, Rynard VL, Burkhalter R. Tobacco Use in Canada: Patterns and Trends, 2014 Edition. Waterloo, ON: Propel Centre for Population Health Impact, University of Waterloo.
- Davis RM. Uniting Physicians Against Smoking: The Need For A Coordinated National Strategy. JAMA 1988; 259:2900–2901.
- Fiore MC, Jaén CR, Baker TB, et al. A Clinical Practice Guideline for Treating Tobacco Use and Dependence: 2008 Update. Am J Prev Med 2000;35(2):158-176.
- National Centre for Smoking Cessation and Training (NCSCT) Very Brief Advice Training Module. Accessible à : http://www.ncsct.co.uk/publication_very-brief-advice.php. Consulté le 11 mai 2015.
- Cummings KM and Hyland A. Impact of Nicotine Replacement Therapy on Smoking Behaviour. Anny Rev Public Health 2005;26:583-599.
- Fiore MC, Jaén CR, Baker TB, et al. Clinical Practice Guideline: Treating Tobacco Use and Dependence: 2008 Update.
- Fowler G. Helping Smokers to Stop: An Evidence-Based Approach. Practitioner 2000 Jan;244(1606):37-41.
- Slama, KJ, Redman, S, Cockburn J, et coll. Community View about the Role of General Practitioners in Disease Prevention Family Practice 1989;6(3):203-209.
- Reid JL, Hammond D, Rynard VL, Burkhalter R. Tobacco Use in Canada: Patterns and Trends, 2015 Edition. Waterloo, ON: Propel Centre for Population Health Impact, University of Waterloo.
- Santé Canada. Le tabagisme et votre corps : Effets de la cigarette sur la santé. Accessible à : http://www.hc-sc.gc.ca/hc-ps/tobac-tabac/body-corps/index-fra.php. Consulté le 11 mai 2015.
- Agence de la santé publique du Canada. Maladie pulmonaire obstructive chronique (MPOC). Accessible à : http://www.phac-aspc.gc.ca/cd-mc/crd-mrc/copd-mpoc-fra.php. Consulté le 11 mai 2015.
- Fondation des maladies du cœur. Statistiques. Accessible à : http://www.heartandstroke.com/site/c.ikIQLcMWJtE/b.3483991/k.34A8/Statistics.htm. Consulté le 11 mai 2015.
- Centers for Disease Control and Prevention. Smoking and Diabetes. Accessible à : http://www.cdc.gov/tobacco/campaign/tips/diseases/diabetes.html. Consulté le 11 mai 2015.
- Stead LF, Bergson G, and Lancaster T. Physician Advice for Smoking Cessation (Review). Cochrane Database of Systematic Reviews 2008; Issue 2.
- Centers for Disease Control and Prevention. Using Proven Treatments Can Double Your Chance of Success. May 11, 2015.
- Bondy SJ, Diemer LM, Victor JC, et coll. Assessing the Reach of Nicotine Replacement Therapy as a Preventive Public Health Measure. Chronic Dis Injur Can 2012;33(1):19-28.
- Gomme NICORETTE®, licence du produit. Le 11 août 2011.
- Lindson-Hawley N, Aveyard P and Hughes JR. Reduction Versus Abrupt Cessation in Smokers Who Want to Quit. Cochrane Database of Systematic Reviews 2012; Issue 11.
- Shiffman S, Hughes JR, Ferguson SG, et coll. Smokers’ Interest in Using Nicotine Replacement to Aid Smoking Reduction. Nicotine Tob Res 2007;9(11): 1177-1182.
- Rapuach T, Brown J, Herbec A, et coll. A Systematic Review of Studies Assessing the Association Between Adherence to Smoking Cessation Medication and Treatment Success. Addiction 2013;109:35-43.
- Tonnesen P, Paoletti P, Gustavsson G, et coll. Higher Dosage Nicotine Patches Increase One-Year Smoking Cessation Rates; Results from the European CEASE Trial. Eur Respir J 1999;13:238-246.
- Burns WK and Levinson AH. Discontinuation of Nicotine Replacement Therapy among Smoking-Cessation Attempters. Am J Prev Med 2008;34(3):212-215.
- Siahpush M, Shaikh R, McCarthy M, et coll. Association Between Duration of Use of Pharmacotherapy and Smoking Cessation from a National Survey. BMJ 2015;5:e006229.
- Ferguson S, Mitchell JG, Shiffman S, et coll. Providing Accurate Safety Information May Increase a Smoker’s Willingness to Use Nicotine Replacement Therapy as Part of a Quit Attempt. Addictive Behav 2011;36:713-716.
- U.S. Department of Health and Human Services (National Cancer Institute). Dispelling Myths About Nicotine Replacement Therapy. Accessible à : http://cancercontrol.cancer.gov/brp/tcrb/documents/MythsaboutNRTFactSheet.pdf. Consulté le 11 mai 2015.
- Food and Drug Administration: Consumer Health Information. Nicotine Replacement Therapy Labels May Change. Accessible à : http://www.fda.gov/ForConsumers/ConsumerUpdates/ucm345087.htm. Consulté le 30 mai 2015.
- Monographie de Champix®. Pfizer Canada Inc. Le 18 novembre 2014.
- Catz SL, Jack LM, McClure JB, et coll. Adherence to Varenicline in the COMPASS Smoking Cessation Intervention Trial. Nicotine Tobacco Res 2011;13(5):361-388.
- Hays JT, Leischow SJ, Lawrence D, et coll. Adherence to Treatment for Tobacco Dependence: Association with Smoking Abstinence and Predictors of Adherence. Nicotine Tobacco Res 2010;12(6):574-581.
- Fucito LM, Toll BA, Salovey P, et coll. Beliefs and Attitudes About Bupropion: Implications for Medication Adherence and Smoking Cessation Treatment. Psychol Addictive Behav 2009;23(2):373-379.
- Organisation mondiale de la santé : Tobacco Smoking. 2003.
- O’Donohue WT and Levensky ER. Promoting Treatment Adherence: A Practical Handbook for Health Care Providers. 2006; Sage Publications, Inc.
- Santé Canada. Sur la voie de la réussite – Guide pour devenir un non-fumeur. Accessible à : http://www.hc-sc.gc.ca/hc-ps/pubs/tobac-tabac/orqa-svra/index-fra.php. Consulté le 11 mai 2015.
- Garvey AJ, Bliss RT, Hitchcock JL, et coll. Predictors of Smoking Relapse Among Self-Quitters: A Report from the Normative Aging Study. Addictive Behav 1992;17:367-377.
- Rigotti NA. Strategies to Help a Smoker who is Struggling to Quit. JAMA 2012;308(15):1573-1580.
- Hughes JR, Gulliver SB, Fenwick JW, et coll. Smoking Cessation Among Self-Quitters. Health Psychol 1992;11(5):331-334.
- Aveyard P and Raw M. Improving Smoking Cessation Approaches at the Individual Level. Tobacco Control 2012;21:252-257.
- Prochaska JO and DiClemente CC. Stages and Processes of Self-Change of Smoking: Toward an Integrative Model of Change. J Consult Clin Psychol 1983;51(3):390-395.
- American Cancer Society. A Word About Success Rates for Quitting Smoking. Accessible à : http://www.cancer.org/healthy/stayawayfromtobacco/guidetoquittingsmoking/guide-to-quitting-smoking-success-rates. Consulté le 11 mai 2015.
- Russell MAH, Wilson C, Taylor C, et coll. Effect of General Practitioners’ Advice Against Smoking BMJ 1979;2(6184):231-235.
- Ockene JK and Zapka JG. Physician-Based Smoking Intervention: A Rededication to a Five-Step Strategy to Smoking Research Addictive Behav 1997;22(6):835-848.
- MDQuit.org. Module 3: The Stages of Change. Accessible à : http://mdquit.org/fax-to-assist/module-3. Consulté le 11 mai 2015.
- How Tobacco Smoking Causes Disease: The Biology and Basis for Smoking-Attributable Disease. A Report of the Surgeon General. 2010.
- Mayo Clinic. Nicotine Dependence. Accessible à : http://www.mayoclinic.org/diseases-conditions/nicotine-dependence/basics/definition/con-20014452. Consulté le 11 mai 2015.
- Fowler JS, Logan J, Wang G-J, et coll. Monoamine Oxidase and Cigarette Smoking Neurotoxicology 2003;24:75-82.
- Sutherland G. Smoking: Can We Really Make a Difference? Heart 2003;89:ii25-27.
- Santé Canada. Aides pour renoncer au tabac. Accessible à : http://www.hc-sc.gc.ca/hc-ps/tobac-tabac/body-corps/aid-fra.php. Consulté le 11 mai 2015.
- Shiffman S, Ferguson SG, Rohay J, et coll. Perceived Safety and Efficacy of Nicotine Replacement Therapies Among US Smokers and Ex-Smokers: Relationship with Use and Compliance. Addiction 2008;103:1371-1378.
- NICODERM®, licence de mise en marché. Le 16 février 2016.
- Houtsmuller EJ, Fant RV, Eissenberg TE, et coll. Flavor Improvement Does Not Increase Abuse Liability of Nicotine Chewing Gum. PharmacolBiochemBehav2002;72:559-568.
- Kipnis S, Killar R, Bonneau P. Tobacco Myths and Myth – Understandings. New York State Office of Health, Wellness and Medical Direction. October, 2007.
- Prix des cigarettes au Canada. Fondation pour la lutte contre le tabac, Ottawa (613) 230-4211. Accessible à : www.nsra-adnf.ca.
- Nielsen, données d’études de marché.
- McDonald J, Coady K and Saltman D. The Postal Code Lottery Of Cancer Prevention In Canada Discrepancies in Public and Private Funding for Smoking Cessation Products. Report Card on Cancer in Canada, 2012-2013.
- Grana RA, Long PM, Benowitz N, et coll. Electronic Cigarettes. Circulation 2014;129:e490-e492.
- Nitzkin JL. The Case in Favor of E-Cigarettes for Tobacco Harm Reduction. Int J Environ Res Public Health 2014;11:6459-6471.
- Polosa R, Rodu B, Caponnetto P, et coll. A Fresh Look At Tobacco Harm Reduction: The Case For The Electronic Cigarette. Harm Red Journ2013;10:1-11.
- Farsalinos KE and Polosa R. Safety Evaluation And Risk Assessment Of Electronic Cigarettes As Tobacco Cigarette Substitutes: A Systematic Review. TherAdv Drug Saf2014;5(2):67-86.
- Inhalateur NICORETTE®, licence de mise en marché. Le 14 décembre 2007.
- Bullen C, Howe C, Laugesen M, et coll. Electronic Cigarettes for Smoking Cessation: A Randomised Controlled Trial. Lancet 2013;382:1629-1637.
- Gennimmata SA. Acute Effect Of E-Cigarette On Pulmonary Function In Healthy Subjects And Smokers. European Respiratory Society Annual Congress 2012, Abstract 7098.
- Vaikali S. Acute Impact Of A Single E-Cigarette Smoking On Symptoms, Vital Signs And Airway Inflammatory Response. European Respiratory Society Annual Congress 2012, Abstract 7207.
- Vardavas CI, Anagnostopoulos N, Jougias M, et coll. Short-Term Pulmonary Effects of Using an Electronic Cigarette. Chest 2012;141(6):1400-1406.
- Jensen RP, Luo W, Pankow JF, et coll. Hidden Formaldehyde in E-Cigarette Aerosols. NEJM 2015;372(4):393-294.
- Sussan R, Gajghate S, Thimmulappa RK, et coll. Exposure to Electronic Cigarettes Impairs Pulmonary Anti-Bacterial and Anti-Viral Defenses in a Mouse Model. PLOS One 2015; DOI:10.1371/journal.pone.0116861.
- Oh AY and Kacker A. Do Electronic Cigarettes Impart a Lower Potential Disease Burden Than Conventional Tobacco Cigarettes?: Review on E-Cigarette Vapor Versus Tobacco Smoke. Laryngoscope 2014; 124:2702-2706.
- Bertholon JF, Becquemin MH, Annesi-Maesano I. Electronic Cigarettes: A Short Review. Respiration 2013;86:433-438.
- Hadwiger ME, Trehy ML, Ye W, et coll. Identification Of Amino-Tadalafil And Rimonabant In Electronic Cigarette Products Using High Pressure Liquid Chromatography With Diode Array And Tandem Mass Spectrometric Detection. J Chromatogr 2010;1217:7547-7555.
- McRobbie H, Bullen C, Hartmann-Boyce J, et coll. Electronic Cigarettes for Smoking Cessation and Reduction (Review). Cochrane Database of Systematic Reviews 2014(12):1-58.
- Bullen C. Electronic Cigarettes for Smoking Cessation, Curr Cardiol Rep 2014;16:538.
- Canadiens en santé : Rappels et avis. Santé Canada déconseille l’usage des cigarettes électroniques. Accessible à : http://www.canadiensensante.gc.ca/recall-alert-rappel-avis/hc-sc/2009/13373a-fra.php. Consulté le 11 mai 2015.
- Alberta Health Services. Tobacco Free Futures Guidelines. 2012. Accessible à : www.tobaccofreefutures.ca.
- Énoncé de position de l’Association canadienne des ergothérapeutes. Le rôle des professionnels de la santé dans l’abandon du tabac (Déclaration conjointe, juin 2001). Accessible à : http://www.caot.ca/default.asp?pageid=245. Consulté le 13 mai 2015.
- CAN-ADAPTT. Algorithme de pharmacothérapie dans les centres de soins de santé de première ligne. Mars 2012-ed. Nov 2013.
- Santé Canada. Cessez de fumer. Accessible à : http://www.hc-sc.gc.ca/hc-ps/tobac-tabac/quit-cesser/index-fra.php. Consulté le 12 mai 2015.
- American Cancer Society. When smokers quit – what are the benefits over time? Accessible à : http://www.cancer.org/healthy/stayawayfromtobacco/guidetoquittingsmoking/guide-to-quitting-smoking-benefits. Consulté le 12 mai 2015.
- RNAO. The Benefits of Quitting Smoking. Accessible à : http://rnao.ca/bpg/guidelines/integrating-smoking-cessation-daily-nursing-practice. Consulté le 13 mai 2015.
- McDermott MS, Marteau TM, Hollands GJ, et coll. Change in Anxiety Following Successful and Unsuccessfully Attempts at Smoking Cessation: Cohort Study. Br J Psych 2013;202:62-67.
- Healthline. The Effects of Smoking on the Body. Accessible à : http://www.healthline.com/health/smoking/effects-on-body. Consulté le 13 mai 2015.
- Cho YH, Jeong DW, Seo SH, et coll. Changes in Skin Color After Smoking Cessation. Korean J Fam Med 2012;33:105-109.
- British Lung Foundation. Smoking and Your Lings: Why it’s Never Too Late to Give Up. Accessible à : https://www.blf.org.uk/Page/Stopping-smoking. Consulté le 11 juin 2015.
- Action on Smoking and Health (UK). Cut Down with Nicorette (nicotine) then Stop Backgrounder. August, 2015. Accessible à : http://www.ash.org.uk/files/documents/ASH_454.pdf. Consulté le 11 mai 2015.
- Hughes JR. Motivating and Helping Smokers to Stop Smoking. J Gen Intern Med 2003;1053-1057.
- Santé Canada. Enquête de surveillance de l’usage du tabac au Canada (ESUTC). Février à décembre 2003.
- HealthLink BC. Quitting Smoking: Coping with Cravings and Withdrawal. Accessible à : http://www.healthlinkbc.ca/healthtopics/content.asp?hwid=zp4066. Consulté le 13 mai 2015.
- HelpGuide.Org. How to Quit Smoking. Accessible à : http://www.helpguide.org/articles/addiction/how-to-quit-smoking.htm. Consulté le 14 mai 2015.
- NHS (UK). Top 5 Tips for Quitting Smoking. Accessible à : http://www.nhs.uk/smokefree/why-quit/quit-smoking-tips. Consulté le 14 mai 2015.
- Cheminer sans fumer. Comment aider un ami à cesser de fumer. Accessible à : http://www.cheminersansfumer.org. Consulté le 14 mai 2015.
- Anczak JD and Nogler RA. Tobacco Cessation in Primary Care: Maximizing Intervention Strategies. Clin Med Res 2003;1(3):201-216.
- Forever Free. A Guide to Remaining Smoke Free. Accessible à : http://foreverfree.et-storefront.com/v5fmsnet/CustomPages/Moffitt/PDFs/Moffitt%20Series%202/S2_book04_Sample.pdf. Consulté le 14 mai 2015.
- NICORETTE® VAPOÉCLAIR®, licence de mise en marché. Le 18 janvier 2013.
- Pastille NICORETTE®, licence de mise en marché. Le 4 août 2011.
- Fagerstrom K and Hughes J. Varenicline In The Treatment Of Tobacco Dependence. Neuropsych Dis Treat 2008;4(2):353-363.
- Koegelenberg CFN, Noor F, Bateman ED, et coll. Efficacy of Varenicline Combined With Nicotine Replacement Therapy vs Varenicline Alone for Smoking Cessation. JAMA 2014;312(2):155-161.
- Tonstad S, Davies S, Flammer M. Psychiatric Adverse Events In Randomized, Double-Blind, Placebo-Controlled Clinical Trials Of Varenicline: A Pooled Analysis. Drug Saf2011;33(4):289-301.
- Spiegler P. Dual Therapy for Smoking Cessation. ClinPulm Med 2014;21:288.
- Warner C and Shoaib M. How Does Bupropion Work as a Smoking Cessation Aid? Addiction Biol2005;10:219-231.
- Monographie de ZYBAN®. Valeant Canada LP. Le 1er août 2013.
- Silagy C, Lancaster T, Stead L, et coll. Nicotine Replacement Therapy for Smoking Cessation (Review). Cochrane Database of Systematic Reviews 2004; Issue 3.
- CAN-ADAPTT. (2011). Canadian Smoking Cessation Clinical Practice Guideline. Toronto, Canada: Canadian Action Network for the Advancement, Dissemination and Adoption of Practice-informed Tobacco Treatment, Centre for Addiction and Mental Health.
- Santé Canada. Le tabagisme et la mortalité. Accessible à : http://www.hc-sc.gc.ca/hc-ps/tobac-tabac/legislation/label-etiquette/mortal-fra.php.
- Santé Canada. Perspectives d’avenir : L’avenir de la lutte fédérale contre le tabagisme. Le 12 septembre 2011. Accessible à : http://www.hc-sc.gc.ca/hc-ps/consult/_2011/foward-avenir/consult-fra.php.
- Asfar T, et al. Do Smoking Reduction Interventions Promote Cessation in Smokers Not Ready to Quit? Addict Behav2011;36:764-768.
- Ellerbeck EF, et al. Effect of Varying Levels of Disease Management on Smoking Cessation. Ann Intern Med 2009;150:437-446.
- Pisinger C, et al. Is it Possible to Help Smokers in Early Motivational Stages to Quit. The Inter99 Study. Prev Med 2005;40:278-284.
- Richter KP. Do we Really Need to Assess Tobacco Users’ Willingness to Quit? Presentation to the University of Kansas School of Medicine.
- Hughes JR, et al. Intentions to Quit Smoking Change Over Short Periods of Time. Addict Behav2005;30:653-662.
- Richter KP, et al. It’s Time to Change the Default for Tobacco Treatment. Addiction 2014;110:381-386.
- Aveyard P, et al. Brief Opportunistic Smoking Cessation Interventions: A Systematic Review and Meta-Analysis to CompareAdvice to Quit and Offer of Assistance. Addiction 2011;107:1066-1073.
- Conroy MB, et al. The Association Between Patient-Reported Receipt of Tobacco Intervention at a Primary Care Visit and Smokers' Satisfaction with their Health Care.Nicotine TO Res 2005;7(Suppl 1):S29-S34.
- Hughes JR. An Updated Algorithm for Choosing Among Smoking Cessation Treatments.J Subst Abuse Treat 2013;45: 215-221.
- Reid RD, Pritchard G, Walker K, et al. Managing Smoking Cessation. CMAJ 2016;188(17-18): E484-E492. Epub 2016 Oct 3.
- Diefenbach L, et al. What is the Most Effective Nicotine Replacement Therapy? J Fam Pract 2003;52(6):492-494.
- Burris JL et al. A Mechanistic Test of Nicotine Replacement Therapy Sampling for Smoking Cessation Induction. Psychol Addict Behav 2015 Jun;29(2):392-399.
- Shiffman S. Nicotine Replacement Therapy Increases Quit Attempts Among Unmotivated Smokers When Added to Encouragement to Practice Quitting. Evidence-Based Medicine 2012;17(6):187-188.
- Hughes JR, et al. Shape of the Relapse Curve and Long-term Abstinence Among Untreated Smokers. Addiction 2004l99:29-38.
- Knight C, et al. The Cost-Effectiveness of an Extended Course (12 + 12 Weeks) of Varenicline Compared with Other Available Smoking Cessation Strategies in the United States: An Extension and Update to the BENESCO Model. Value in Health 2010;13(2):209-214.
- Anthenelli RM, et al. Neuropsychiatric safety and efficacy of varenicline, bupropion, and nicotine patch in smokers with and without psychiatric disorders (EAGLES): a double-blind, randomised, placebo-controlled clinical trial. Lancet 387(10037):2507-2520.
- Chang P-H, et al. Combination therapy of varenicline with nicotine replacement therapy is better than varenicline alone: a systematic review and meta-analysis of randomized controlled trials. BMC Pub Health 2015;15:689.
- Kaplan A. Can electronic cigarettes assist patients with smoking cessation?: Yes. Can Fam Physician 2015;61:499-500.
- Garcia-Arcos I, et al. Chronic Electronic Cigarette Exposure in Mice Induces Features of COPD in a Nicotine-Dependent Manner. Thorax 2016;71:1119-1129. doi:10.1136/thoraxjnl-2015-208039.
- Sherwood C and Boitano B. Airway Epithelial Cell Exposure to Dstinct E-cigarette Liquid Flavorings Reveals Toxicity Thresholds and Activation of CFTR by the Chocolate Flavoring 2,5-Dimethypyrazine Features of COPD in a Nicotine-Dependent Manner. Respiratory Research 2016;17:57 DOI 10.1186/s12931-016-0369-9.
- Siegel MB, Tanwar KL, Wood KS. Electronic Cigarettes as a Smoking-Cessation Tool: Results From an Online Survey. Am J Prev Med 2011;40:472-475.
- Beiner L and Hargraves JL. A Longitudinal Study of Electronic Cigarette Use in a Population-Based Sample of Adult Smokers: Association With Smoking Cessation and Motivation to Quit. Nicotine Tob Res 2014;doi: 10.1093/ntr/ntu200.
- Malas M, van der Tempel J, Schwartz R, et al. Electronic cigarettes for smoking cessation: A systematic review. Nicotine Tob Res 2016;18(10):1926-1936.
- Fairchild A, Bayer R, Colgrove J. The Renormalization of Smoking? E-Cigarettes and the Tobacco “Endgame” N Engl J Med 2014; 370:293-295January 23, 2014DOI: 10.1056/NEJMp1313940.
- Czoli C, Hammond D, White C. Electronic cigarettes in Canada: Prevalence of use and perceptions among youth and young adults. Can J Public Health 2014;105(2):e97-e102.
- Schripp T, Markewitz D, Uhde E, et al. Does e-cigarette consumption cause passive vaping? Indoor Air. 2013;23:25–31.
- Liste des additifs alimentaires autorisés au Canada. Santé Canada. Accessible à : https://www.canada.ca/fr/sante-canada/services/aliments-nutrition/salubrite-aliments/additifs-alimentaires/dictionnaire/autorises-canada.html.
- Westenberger B.J. “Evaluation of e-cigarettes.” Food and Drug Association, Department of Health and Human Services, 4 May 2009. Accessible à : http://www.fda.gov/downloads/drugs/Scienceresearch/UCM173250.pdf.
- National Institutes of Health, National Cancer Institute. Why do you smoke? Accessible à : http://dccps.nic.nih.gov/TCRB/why_do_you-smoke/why.html.
- Shah SD et al. Systematic review and meta-analysis of combination therapy for smoking cessation. J Amer Pharm Assoc Sept-Oct 2008; 48:5.